Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Tom's of Maine non-animal test shows original toothpaste formula effectiveness, FDA says.

This article was originally published in The Tan Sheet

Executive Summary

TOM'S OF MAINE DENTIFRICE FORMULATIONS MUST BE INDIVIDUALLY TESTED for effectiveness, FDA told the Kennebunk, Maine-based company in a recent letter. Tom's had asked the agency in a Feb. 16 citizen petition to accept data from an intra-oral remineralization test in humans using the original Tom's Natural Toothpaste formula to show bioavailability of the fluoride ion in all of its fluoride toothpastes ("The Tan Sheet" March 4, p. 5). The company's corporate philosophy of not testing its products in animals conflicts with the OTC anticaries final monograph requirement that bioavailability be demonstrated through animal testing. Tom's is proceeding with testing its other toothpaste formulas.

You may also be interested in...



Tom’s Of Maine Original Formula’s Use As Reference Standard Urged

Tom's of Maine intends to market new dentifrice products formulated with sodium monofluoro-phosphate in a calcium-only abrasive system pending reference standard testing for fluoride bioavailability, according to the Kennebunk, Maine company

Tom’s Of Maine Original Formula’s Use As Reference Standard Urged

Tom's of Maine intends to market new dentifrice products formulated with sodium monofluoro-phosphate in a calcium-only abrasive system pending reference standard testing for fluoride bioavailability, according to the Kennebunk, Maine company

Anticaries Alternative Test Review Should Include Multiple Methods – CHPA

FDA should evaluate multiple alternative test methods in addition to the intraoral appliance (IOA) model as it considers non-animal test methods for OTC anticaries products, according to the CHPA/CTFA Anticaries Task Group

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS086278

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel